Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Cryo nerve block to improve recovery after bilateral lung transplant

Official title: Evaluating the Impact of Cryo-analgesia on Recovery After Double Lung Transplantation: a Pilot Study

Run by University Hospital, Gasthuisberg · NCT06959056 · Data updated 2026-11-12

This pilot will test whether adding a cryo nerve block around the chest helps people with end-stage COPD recover better after a bilateral lung transplant.

More Lung Transplant trials

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment40 (estimated)
SponsorUniversity Hospital, Gasthuisberg
Academic / other
Locations1 site (Leuven, Vlaams-Brabant)
StatusRecruiting
StartedJanuary 4, 2026
Main results expectedDecember 31, 2026
Study endsDecember 2027
Registry record updatedJune 5, 2026
Trial IDNCT06959056 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults (18+) with end-stage COPD scheduled for bilateral lung transplantation at University Hospitals Leuven who can give informed consent and are not chronic preoperative opioid users are the intended participants.

Probably not a fit

Patients receiving unilateral or lobar transplants, combined organ transplants, donor lungs treated with EVLP, or those with chronic preoperative opioid use are excluded and unlikely to benefit from this protocol.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This pilot interventional study delivers cryo-analgesia to the T3–T8 intercostal nerves bilaterally at the time of bilateral lung transplantation to alter chest sensation and postoperative pain. It will compare patients receiving the cryo nerve block with standard care and measure highest pain scores, opioid (morphine) requirements, lung function, ICU length of stay, complications, and quality of life in both short and long term. The study is designed to estimate effect sizes and identify which outcomes may be impacted to inform larger trials rather than to provide definitive efficacy results. All procedures and follow-up take place at a single high-volume European transplant center (University Hospitals Leuven) in adults with end-stage COPD.

Why it matters

Potential benefit: If successful, cryo-analgesia could reduce postoperative chest pain and opioid use, shorten ICU stay, and improve overall recovery and quality of life after bilateral lung transplantation.

How similar studies have gone: Cryoanalgesia has shown short-term pain and opioid-sparing benefits in some thoracic surgery settings, but its application specifically after lung transplantation is novel and not well studied.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Voluntary written informed consent of the participant or their legally authorized representative has been obtained prior to any screening procedures
2. At least 18 years of age at the time of signing the Informed Consent Form (ICF)
3. Bilateral lung transplantation at UZ Leuven
4. Indication for transplantation: End stage chronic obstructive pulmonary disease (COPD)
5. Storage of lungs on classic ice, cooled system (LUNGguard® (Paragonix) or X°Port Lung Transport Device (Traferox Technologies Inc.) ) are all permitted
6. Patients that have undergone lung volume reduction or talcage are not a contraindication for participation in the study.

Exclusion Criteria:

1. Unilateral lung transplantation
2. Lobar transplantation
3. Donor lung reconditioning using ex-vivo lung perfusion (EVLP)
4. Combined organ transplantation
5. Chronic opioid use pre-operatively
6. Participation in an interventional Trial with an investigational medicinal product (IMP) or device (IMD) that could potentially influence the post-operative outcomes of this study

Where it's running

  • University Hospitals Leuven
    Leuven, Vlaams-Brabant, Belgium
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.